Human SARS immunoglobulin (Wuhan Institute of Biological Products)
静脉注射用人SARS免疫球蛋白（武汉生物制品研究所）
Report date: 2025/06/26 17:37:44
Base Information
Drug NameHuman SARS immunoglobulin (Wuhan Institute of Biological Products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesWuhan Institute Of Biological Products Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A